Evaluation of the Psychosocial Status of Patients With Type 2 Diabetes Mellitus and Their Treating Physicians Using the Glycemic Happiness Scale: A Multicentric, Cross-sectional Study.

BACKGROUND

The purpose of this study was to evaluate the psychosocial status of patients with type 2 diabetes (T2D) and treating physicians using a novel Glycemic Happiness (GH) scale.

METHODS

This was a real-world, prospective, multicentric, cross-sectional observational study. Male and female participants aged ≥ 18 years with a clinical diagnosis of T2D were eligible to take part. Additionally, the physicians with extensive T2D patient experience were enrolled in the study.

RESULTS

The study included a total of 400 participants of T2D and 27 physicians. The patient population consisted of 213 (53.3%) men and 187 (46.7%) women, with a mean age of 54.29 ± 12.05 years. The proportions of patients and physicians who were found to be happy were 50.5% and 90.8%, respectively. A statistically significant difference was found in the mean value of the GH score of insulin and oral antidiabetic drugs (OAD) for the physician component (P=0.0160). Although no significant difference in GH score was observed between insulin and OAD usage among the patients (P=0.9564), a significant difference was observed for dosage frequency of OAD (Once daily (OD) vs. three times daily (TID) (P=0.0034) and twice daily (BID) vs. TID (P=0.0324)). In the multiple regression analysis, GH in patients was found to be associated with glycated hemoglobin (HbA1c) and postprandial glucose (PPG) values.

CONCLUSIONS

High glucose levels and OAD dosage frequency have been negatively associated with GH in patients with T2D. To achieve long-term happiness and well-being in diabetes management, there is a need to focus on various aspects of GH among patients and physicians.